voice searchcamera search
Dactinom (Dactinomycin Injection 0.5mg)

Dactinom (Dactinomycin Injection 0.5mg)

Price: 346.50 INR / Unit

(330.00 INR + 5% GST)

Get Latest Price

MRP:

346.50 INR / Unit

Weight :

20.00 Gram

1 Pack Contains :

1

Minimum Pack Size :

100

In Stock

In Stock

-100+

Product Specifications

Salt Composition0.5 Mg
IndicationCancer Treatment
OriginIndia
Dosage FormInjection
FeatureOther
IngredientsOther
ApplicationOther
Storage InstructionsCool & Dry Place
FOB PortMUMBAI
Payment TermsCash Advance (CA), Cash in Advance (CID), Letter of Credit at Sight (Sight L/C), Letter of Credit (L/C), Telegraphic Transfer (T/T)
Supply Ability1000 Per Week
Delivery Time1 Week
Sample AvailableNo
Sample PolicyContact us for information regarding our sample policy
Packaging Details1 PC PER BOX
Main Export Market(s)Asia, Middle East, Africa
Main Domestic MarketAll India
CertificationsWHO-GMP, EU-GMP
Shipping Typeactual
Pkg Box Breadth3.00 inches
Mop100
Weight20.00 Gram
Stock Quantity1000
Brand NameDACTINOM
MRP346.50 INR
Unit TypeUnit/Units
Pkg Box Length3.50 inches
Pkg Box Height3.50 inches
ReturnableNo
Price Typefixed
Product Unit100 Unit/Units
Packsize1
GSTIN5%
CurrencyINR
Price330.00 INR (Approx.)
Minimum Ordered Packs100

Product Overview

Key Features



DACTINOM(Dactinomycin 0.5 mg)is a chemotherapy drug classified as anantineoplastic antibiotic. It is used to treat various cancers by inhibiting DNA synthesis and causing tumor cell death.
Indications

Dactinomycin is FDA-approved and used in combination with other therapies for:

  1. Wilms Tumor :Often used as part of a multi-agent regimen in pediatric patients.

  2. Rhabdomyosarcoma :Primarily in pediatric patients, combined with surgery and/or radiation.

  3. Ewing Sarcoma :Frequently combined with other chemotherapeutic agents.

  4. Gestational Trophoblastic Neoplasia (GTN) :Used in high-risk or refractory cases.

  5. Metastatic Nonseminomatous Testicular Cancer :As part of salvage therapy regimens.

  6. Other Off-Label Uses :May be used for desmoid tumors or Kaposi sarcoma in selected cases.

Mechanism of Action

Dactinomycin intercalates into DNA, interfering with RNA synthesis and causing DNA strand breaks. This inhibits tumor growth by:

  1. Blocking Transcription :Prevents RNA polymerase from functioning.

  2. Inducing Apoptosis :DNA damage triggers programmed cell death in rapidly dividing tumor cells.

Dosage and AdministrationTypical Doses :
  • 0.015 mg/kg/dayor400-600 mcg/m/dayfor 5 days, continue every 3-4 weeks depending on the cancer type.

Preparation:

* Reconstitute with sterile water for injection.

* Use immediately after reconstitution; store as per stability guidelines.

Administration:

* 0Intravenous (IV) Only :Administer via slow IV push or infusion to minimize toxicity.

* Avoid extravasation, as it can cause severe tissue damage.

Common Side EffectsFrequent (>20%):
  1. Gastrointestinal :Nausea, vomiting, stomatitis, and diarrhea.
  2. Hematologic :Myelosuppression (neutropenia, anemia, thrombocytopenia).
  3. Fatigue and Weakness :Generalized but reversible.
Mild to Moderate :Skin rash, alopecia, fever.Severe or Rare Side Effects
  1. Tissue Necrosis :Extravasation can lead to severe local tissue injury and necrosis.
  2. Hepatotoxicity :Elevated liver enzymes or veno-occlusive disease, particularly in children.
  3. Severe Myelosuppression :Can result in life-threatening infections or bleeding.
  4. Secondary Malignancies :Rare but possible long-term risk.
  5. Hypersensitivity Reactions :Rash, urticaria, or anaphylaxis in rare cases.
Monitoring and PrecautionsBaseline and Periodic Monitoring :Complete Blood Count (CBC), Liver Function Tests (LFTs), Renal Function, Injection Site
Precautions:
  1. Pregnancy and Breastfeeding
  2. Handling Precautions
  3. Extravasation:Immediate interventions include stopping infusion and applying antidotes likedimethyl sulfoxide (DMSO).
Clinical Effectiveness
  1. Wilms Tumor :Improves survival rates when combined with surgery, radiation, and other chemotherapies.
  2. Rhabdomyosarcoma :Effective as part of multi-agent therapy in achieving remission.
  3. Gestational Trophoblastic Neoplasia (GTN)
Drug Interactions
  1. Hepatotoxic Drugs :Concurrent use (e.g., methotrexate) may exacerbate liver damage.
  2. Radiation Therapy :Increased risk of radiation recall reactions (severe skin or tissue inflammation at irradiated sites).
Practical Tips for PatientsHydration, Infection Prevention, Skin Protection, Symptom Monitoring

Company Details

Established in 2023, MEDONCO PHARMA has made a name for itself in the list of top suppliers of Cancer, TB & Tumor Drugs in India. The supplier company is located in Dehradun, Uttarakhand, and is one of the leading sellers of listed products.
MEDONCO PHARMA is listed in Trade India's list of verified sellers offering supreme quality of Abiramed Abiraterone Acetate Tablets 250mg, Aximed Axitinib 5mg Tablets, Bortemed Bortezomib Injection 2mg, etc. Buy Cancer, TB & Tumor Drugs in bulk from us for the best quality products and service.

Business Type

Exporter, Manufacturer, Supplier

Employee Count

5

Establishment

2023

Working Days

To

GST NO

05AARCM4867D1Z6

Payment Mode

Others

More Products From This Seller

Seller Details

GST

GST - 05AARCM4867D1Z6

Dehradun, Uttarakhand

MARKETING MANAGER

Mr. Neeraj Gunprakash

Address

51, KANDOLI, RAJPUR ROAD, Dehradun, Uttarakhand, 248001, India

Cancer, TB & Tumor Drugs in Dehradun

Report incorrect details